The goal of this collaborative was to examine the contributing factors towards the failure of late-stage clinical product development and develop key considerations for stakeholders to improve the ...
MUNICH & SAN FRANCISCO--(BUSINESS WIRE)--CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today announced changes to its executive leadership team to support its next stage of ...
Pfizer PFE has strengthened its R&D pipeline through M&A deals and clinical trial success over the past decade. Pfizer has particularly advanced its oncology pipeline with several candidates entering ...
Pfizer has strengthened its R&D pipeline through M&A deals and clinical trial success. PFE is advancing key oncology and vaccine candidates, with several in late-stage development. PFE trades below ...
One in four new drugs approved in the US between January 2008 and December 2017 received direct funding from public resources for late stage research or through spin-off companies created from public ...
What is the work you’re leading at Immatics as VP of Late-Stage Cell Therapy Development? I am leading a cross-functional team with the goal to obtain regulatory approval of a PRAME-directed TCR-T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results